Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	67,912	67,449	74,026	84,502	72,102	58,059
Market Cap Growth	-7.59%	-8.88%	-12.40%	17.20%	24.19%	39.28%
Enterprise Value	54,422	53,802	58,974	72,751	62,474	50,391
Last Close Price	654.00	666.00	672.24	787.16	664.49	566.06
PE Ratio	17.70	17.58	17.37	23.63	17.76	8.18
PS Ratio	5.56	5.52	5.40	7.12	6.33	4.11
PB Ratio	2.55	2.53	2.61	3.60	3.40	3.52
P/TBV Ratio	2.66	2.64	2.72	3.75	3.54	3.52
P/FCF Ratio	19.54	19.41	20.91	24.10	17.42	10.11
P/OCF Ratio	16.02	15.91	17.34	20.33	15.37	9.32
EV/Sales Ratio	4.47	4.40	4.30	6.13	5.49	3.57
EV/EBITDA Ratio	14.98	14.88	13.19	17.28	12.51	6.18
EV/EBIT Ratio	17.32	17.06	14.73	19.00	13.37	6.37
EV/FCF Ratio	15.66	15.48	16.66	20.75	15.09	8.78
Debt / Equity Ratio	0.10	0.10	0.10	0.11	0.12	0.14
Debt / EBITDA Ratio	0.69	0.69	0.63	0.60	0.52	0.29
Debt / FCF Ratio	0.73	0.73	0.80	0.72	0.63	0.41
Net Debt / Equity Ratio	-0.51	-0.51	-0.51	-0.52	-0.51	-0.52
Net Debt / EBITDA Ratio	-3.74	-3.74	-3.23	-2.89	-2.17	-1.06
Net Debt / FCF Ratio	-3.89	-3.89	-4.09	-3.47	-2.61	-1.51
Asset Turnover	0.37	0.37	0.40	0.42	0.45	0.76
Inventory Turnover	2.53	2.53	2.51	2.51	2.37	2.74
Quick Ratio	3.28	3.28	3.86	4.82	4.16	2.98
Current Ratio	4.13	4.13	4.73	5.69	5.06	3.56
Return on Equity (ROE)	14.87%	14.87%	15.95%	16.26%	20.94%	54.21%
Return on Assets (ROA)	5.91%	5.91%	7.31%	8.49%	11.42%	26.39%
Return on Invested Capital (ROIC)	12.54%	13.04%	18.58%	22.38%	26.65%	60.13%
Return on Capital Employed (ROCE)	10.20%	10.20%	12.30%	14.30%	19.20%	41.80%
Earnings Yield	5.65%	5.69%	5.76%	4.23%	5.63%	12.23%
FCF Yield	5.12%	5.15%	4.78%	4.15%	5.74%	9.89%
Dividend Yield	0.47%	0.45%	-	-	-	-
Payout Ratio	8.76%	8.22%	-	-	-	-
Buyback Yield / Dilution	5.65%	5.65%	-1.23%	-0.18%	-1.16%	2.52%
Total Shareholder Return	6.12%	6.10%	-1.23%	-0.18%	-1.16%	2.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.